Cost-effectiveness of CD34+ dose in peripheral blood progenitor cell transplantation for non-Hodgkin's lymphoma patients: a single centre study.

Limat, S; Woronoff-Lemsi, M C; Deconinck, E; Racadot, E; Jacquet, M; Herve, P; Cahn, J Y

Limat, S; Woronoff-Lemsi, M C; Deconinck, E; Racadot, E; Jacquet, M; Herve, P; Cahn, J Y.

Affiliation

Limat S; Department of Pharmacy, Besançon University Hospital, Besançon, France.

Bone Marrow Transplant ; 25(9): 997-1002, 2000 May.

Article in En | MEDLINE | ID: mdl-10800070

Subject(s)

Hematopoietic Stem Cell Transplantation/economics; Lymphoma, Non-Hodgkin/therapy; Adult; Antigens, CD34; Cost-Benefit Analysis; Female; Humans; Lymphoma, Non-Hodgkin/economics; Male; Middle Aged; Retrospective Studies

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Hematopoietic Stem Cell Transplantation Type of study: Health_economic_evaluation / Observational_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2000 Type: Article Affiliation country: France

Search on Google

XML

PubMed Links